Meatable and Whispp:TIME’s Best Inventions 2024


We’re proud to announce that two innovations from Leiden Bio Science Park, Meatable and Whispp, were named among TIME’s Best Inventions of 2024, recognized for their meaningful impact on communication and sustainable food production.

 Whispp: Accessible Communication

 Whispp, founded by Joris Castermans and Akash Raj Komarlu in 2018, developed a real-time, audio-to-audio solution that converts whispered or affected speech into a clear, natural voice. Designed to support people with voice disabilities, Whispp’s AI-driven technology enables smooth communication across calls, video chats, and messages, without the delays of traditional assistive devices. Named in the Accessibility category, Whispp’s innovation brings freedom and confidence to daily conversations.

 Meatable: Sustainable Meat Production

 Meatable’s approach to lab-grown meat, recognized in TIME’s Best Inventions list, addresses the environmental challenges of industrial meat production. Using their patented Opti-Ox™ technology, Meatable grows muscle and fat cells from pluripotent stem cells in four days, creating real animal meat without harm to animals or the environment. With plans to launch in Singapore next year, Meatable offers a solution to meet demand for meat without the environmental toll.

These honors underscore Leiden Bio Science Park’s role in supporting technologies that drive change in healthcare, sustainability, and beyond.


  • LUMC opens dedicated CAR-T department

    Leiden University Medical Center (LUMC) has opened a dedicated department for CAR-T cell therapy, bringing care, research and expertise in this rapidly developing field together in one place. The new department, officially opened on 24 September, marks another step in…

  • VarmX recognised with two prestigious industry award nominations

    Leiden-based biotech company VarmX has received two industry award nominations recognising its scientific approach and strategic partnership with CSL. VarmX has been shortlisted for the 2026 Prix Galien USA “Best Startup” Award, which recognises early-stage companies developing novel therapeutic approaches.…